Provided by Tiger Trade Technology Pte. Ltd.

GSK plc ADRhedged

66.92
-0.4505-0.67%
Volume:215
Turnover:14.38K
Market Cap:669.27K
PE:- -
High:66.92
Open:66.92
Low:66.92
Close:67.37
52wk High:85.03
52wk Low:60.91
Shares:10.00K
Float Shares:10.00K
Volume Ratio:6.99
T/O Rate:2.15%
Dividend:2.08
Dividend Rate:3.11%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Novartis Bets $7.8 Billion On MRNA Beyond Vaccines

Options & Short Sell
·
5 hours ago

GlaxoSmithKline (GSK) Gets a Sell from J.P. Morgan

TIPRANKS
·
Yesterday

GSK Slides Wednesday, Underperforms Market

Dow Jones
·
Yesterday

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

MT Newswires Live
·
Sep 30

Jefferies Remains a Buy on GlaxoSmithKline (GSK)

TIPRANKS
·
Sep 29

$20 Billion In Deals And Counting: Lilly's CEO Targets The "White Space" Of Science For Larger M&A

Options & Short Sell
·
Sep 29

AstraZeneca To Invest $2 Billion In Summit And Co-Develop Drugs; Shares Jump After Hours

Options & Short Sell
·
Sep 29

GSK Falls Friday, Underperforms Market

Dow Jones
·
Sep 26

Pharmaceutical Stocks Jump. Moderna, Eli Lilly up over 3%; Novavax, Pfizer up Around 2%; Merck, Novo Nordisk up over 1%

Tiger Newspress
·
Sep 24

European Pharma Leaders Push for National Reforms to Boost Investment

Dow Jones
·
Sep 22

GSK Rallies Monday, Outperforms Market

Dow Jones
·
Sep 22

European Equities Traded in the US as American depositary Receipts Rise in Monday Trading

MT Newswires Live
·
Sep 21

Innovative Drug Sector Heats Up: Spotlight on Pure-Play R&D Developers

Deep News
·
Sep 21

UBS Remains a Hold on GlaxoSmithKline (GSK)

TIPRANKS
·
Sep 18

GSK Climbs Thursday, Outperforms Market

Dow Jones
·
Sep 18

Positive Report for GlaxoSmithKline (GSK) from Berenberg Bank

TIPRANKS
·
Sep 16

Sector Update: Healthcare

MT Newswires Live
·
Sep 16

Is the Shingles Vaccine the Secret to Living Longer and Delaying Dementia? Here's What the Science Says.

Dow Jones
·
Sep 15

GSK upgraded to Buy from Hold at Berenberg

TIPRANKS
·
Sep 15

GSK Doubles Down On Oncology: Buys Global Rights To Chimagen's Trispecific TCE For Up To $750 Million

Options & Short Sell
·
Sep 15